SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
SB 515 extends Tennessee's current limit of 125 new nursing home beds per fiscal year for which the health facilities commission may approve (via certificate of need) until June 30, 2029, instead of expiring in 2025. This directly affects nursing home facilities seeking to expand and the health facilities commission, which reviews and approves new bed applications. The key provision is a simple extension of the existing cap, not a change to the 125-bed limit. The bill became effective March 25, 2025, after being signed by the Governor.
SB 318, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants sourced from the People's Republic of China or performed there, effective January 1, 2026. It also bans medical and research facilities from using genetic sequencing equipment or software produced by or linked to "foreign adversaries" (defined as nations on U.S. sanctions lists), requiring replacement within 180 days. The bill restricts storage of genetic sequencing data to U.S. geographic locations and prohibits remote access from outside the U.S. without state health commissioner approval. These provisions directly affect health insurers, hospitals, and research facilities operating in Tennessee.
HB 395, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants or post-transplant care if the organ was sourced from China or procured through sale/donation originating in China. It also bans medical and research facilities from using genetic sequencing equipment or software produced by entities linked to "foreign adversaries" (specifically targeting China per the bill's context), requiring replacement within 180 days. Additionally, the bill mandates that all genetic sequencing data must be stored within the United States, with remote access from outside the country prohibited without approval from the state health commissioner. The law takes effect on January 1, 2026, directly affecting health insurers, hospitals, and research facilities operating in Tennessee.
